ALBANY MOLECULAR RESEARCH INC 3 SEC Filings

Filed On	Filing
28 Dec 2016	Form 3: Conway Christopher M., SVP, Discovery and Development Holds 42,018 shares of COMMON STOCK
28 Dec 2016	Form 3: Fine Margalit, Executive Vice President, API No securities owned
28 Dec 2016	Form 3: Boyer Milton, SVP Drug Product Manufacturing Holds 29,441 shares of COMMON STOCK
12 Oct 2016	Form 3: Mandarin Capital Partners Secondary Sca Sicar, Affiliate of Owner and 1 other Holds 7,051,295 shares of Common Stock
18 Jul 2016	Form 3: Lauro Cinquantasette S.p.A., Director and 2 others Holds 7,051,295 shares of Common Stock
14 Jul 2016	Form 3: Napolitano Fernando, Director No securities owned
04 May 2016	Form 3: Hagen Kenneth Paul, Director No securities owned
19 Feb 2016	Form 3: Deming David H, Director No securities owned
08 Feb 2016	Form 3: Maddaluna Anthony J, Director No securities owned
24 Dec 2015	Form 3: D'Ambra David, 10% owner Holds 3,880,983 shares of Common Stock
20 Jul 2015	Form 3: Gutierrez Fuentes Luis Gerardo, Director No securities owned
13 Feb 2015	Form 3: Ladin Felicia I, SVP & Treasurer Holds 0 shares of No securities are beneficially owned
10 Jan 2014	Form 3: Svokos George, Sr. VP Sales & GM of API Holds 30,000 shares of Common Stock
06 Nov 2013	Form 3: Luther Michael A, Senior VP, Discovery Services Holds 20,000 shares of Common Stock
07 Jan 2013	Form 3: Thomas Dambra Slat Trust, 10% owner and 1 other Holds 375,000 shares of Common Stock
24 Sep 2012	Form 3: Nolan Michael M, VP, CFO and Treasurer Holds 50,000 shares of Common Stock
14 May 2012	Form 3: Marth William S, Director No securities owned
08 Apr 2011	Form 3: Cable Stuart M, 10% owner Holds 3,065,189 shares of Common Stock
11 Feb 2011	Form 3: Sargent Bruce J, Sr VP, Drug Discovery Holds 32,380 shares of Common Stock
11 Feb 2011	Form 3: Henderson Lori M, VP, general counsel Holds 10,000 shares of Common Stock

Comments